Literature DB >> 7076865

Circulating immune complexes and complement concentrations in patients with alcoholic liver disease.

C Gluud, H Jans.   

Abstract

A prospective evaluation of circulating immune complexes (CIC) and the activity of the complement system was undertaken in 53 alcoholic patients just before diagnostic liver biopsy. Circulating immune complexes were detected in 39% of patients with alcoholic steatosis (n = 26), 58% of patients with alcoholic hepatitis (n = 12), and 60% of patients with alcoholic cirrhosis (n = 15). No significant difference was found between the three group of patients. The activity of the complement system was within reference limits in the majority of patients and only slight differences were detected between the three groups. No significant differences were observed in liver biochemistry and complement concentrations in CIC-positive and CIC-negative patients. Detection of CIC in patients with alcoholic liver disease does not seem to be of any diagnostic value or play any pathogenic role. The high prevalence of CIC in these patients may be due to a depressing effect of ethanol on clearance of CIC or to increased immunological reactivity, or to both.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076865      PMCID: PMC497665          DOI: 10.1136/jcp.35.4.380

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Changing pattern of alcoholic liver disease in Great Britain: relation to sex and signs of autoimmunity.

Authors:  N Krasner; M Davis; B Portmann; R Williams
Journal:  Br Med J       Date:  1977-06-11

2.  Detection and differentiation of immune complexes and IgG aggregates by a complement consumption assay.

Authors:  H Nielsen; S R Svehag
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-08

3.  Acute hepatitis: significance of changes in complement components.

Authors:  J A Charlesworth; S Lawrence; P A Worsdall; L P Roy; C R Boughton
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

4.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

5.  Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.

Authors:  P Teisberg; E Gjone
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

6.  Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease.

Authors:  R J Bailey; N Krasner; A L Eddleston; R Williams; D E Tee; D Doniach; L A Kennedy; J R Batchelor
Journal:  Br Med J       Date:  1976-09-25

7.  The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity.

Authors:  H C Thomas; C R Singer; N L Tilney; H Folch; R N MacSween
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

8.  The serum concentration of the third component of complement beta-1C-beta-1A in liver disease.

Authors:  R A Fox; F J Dudley; S Sherlock
Journal:  Gut       Date:  1971-07       Impact factor: 23.059

9.  Detection of circulating immune complexes in pathological human sera.

Authors:  A H Johnson; J F Mowbray; K A Porter
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

10.  Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation.

Authors:  M Mannik; M P Arend; A P Hall; B C Gilliland
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

View more
  1 in total

1.  Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality.

Authors:  C Homann; K Varming; K Høgåsen; T E Mollnes; N Graudal; A C Thomsen; P Garred
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.